Get the Stockscreener App
0.4866
5.51%
-0.0284
After Hours:
.525
0.0384
+7.89%
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Forecast
The Brainstorm Cell Therapeutics, Inc. (BCLI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.7608, representing a +56.36% increase from the current price of $0.4866. The highest analyst price target is $1.0409, and the lowest is $0.4807.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCLI Price Target
Average 3.5188
(+623.13% Upside)
Is Brainstorm Cell Therapeutics, Inc. (BCLI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.59 | Neutral |
| STOCH(9,6) | 35.60 | Neutral |
| STOCHRSI(14) | 16.30 | Buy |
| MACD(12,26) | 0.00741 | Sell |
| ADX(14) | 18.77 | Neutral |
| William %R | -74.88 | Neutral |
| CCI(14) | -93.81 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5442
Sell
|
0.5228
Sell
|
| MA20 |
0.4982
Sell
|
0.5171
Sell
|
| MA50 |
0.5425
Sell
|
0.4994
Sell
|
| MA100 |
0.4449
Buy
|
0.4976
Sell
|
| MA200 |
0.4933
Sell
|
0.7719
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, BCLI could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BCLI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.59 indicates that BCLI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.6 indicates that BCLI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 16.3 indicates that BCLI is oversold. This suggests that BCLI price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.77 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -93.81 indicates that BCLI is still oversold but not to an extreme extent.
Long-term BCLI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Brainstorm Cell Therapeutics, Inc. financial reports and earnings history, Brainstorm Cell Therapeutics, Inc. (BCLI) stock could reach $3.2546 by 2030, $0.2334 by 2040 and $5.8041 by 2050. See the projected annual prices until 2050 of the Brainstorm Cell Therapeutics, Inc. stock below:
- Brainstorm Cell Therapeutics, Inc. (BCLI) is expected to reach an average price of $1.121 in 2035, with a high prediction of $1.2945 and a low estimate of $1.1954. This indicates an $130.37% rise from the last recorded price of $0.4866.
- Brainstorm Cell Therapeutics, Inc. (BCLI) stock is projected to chart a bullish course in 2040, with an average price target of $0.2496, representing an $-48.71% surge from its current level. The forecast ranges from a conservative $0.4896 to a sky-high $0.2334.
- Our analysts predict Brainstorm Cell Therapeutics, Inc. (BCLI) to jump 276.25% by 2045, soaring from $1.7434 to an average price of $1.8308, potentially reaching $1.406. While $1.7434 is the low estimate, the potential upside is significant.
- Brainstorm Cell Therapeutics, Inc. (BCLI) stock is expected to climb by 2050, reaching an average of $5.3645, a $1,002% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.8041 and $5.7345, respectively, highlighting the market's uncertainty.
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Year by Year Forecast
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Price Forecast for 2024
Our forecast for BCLI stock price in 2024 now indicates an average price target of $0.5522 with a high forecast of $1.0409 and a low forecast of $0.0635. The average prediction reflects an increase of +13.48% from the last recorded price of $0.4866.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2024 | $0.7622 | $0.4807 | $1.0409 | +56.64% |
| August, 2024 | $0.2948 | $0.0635 | $0.6228 | -39.42% |
| September, 2024 | $0.7473 | $0.2954 | $0.7973 | +53.58% |
| October, 2024 | $0.6506 | $0.4793 | $0.758 | +33.69% |
| November, 2024 | $0.5831 | $0.3518 | $0.7312 | +19.84% |
| December, 2024 | $0.7857 | $0.4138 | $0.8757 | +61.47% |
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Price Forecast for 2025
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) is expected to reach an average price of $7.9274 in 2025, with a high prediction of $15.32 and a low estimate of $0.537. This indicates an +1,529% rise from the last recorded price of $0.4866.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.0689 | $0.537 | $1.3589 | +119.67% |
| February, 2025 | $1.0115 | $0.9015 | $1.3602 | +107.86% |
| March, 2025 | $3.864 | $0.9121 | $6.974 | +694.09% |
| April, 2025 | $1.4973 | $1.186 | $5.7247 | +207.70% |
| May, 2025 | $3.2918 | $1.3579 | $3.4498 | +576.49% |
| June, 2025 | $2.3924 | $2.1624 | $4.5117 | +391.65% |
| July, 2025 | $7.4156 | $2.183 | $7.7156 | +1,424% |
| August, 2025 | $10.46 | $6.3962 | $10.78 | +2,049% |
| September, 2025 | $10.04 | $9.2507 | $14.43 | +1,963% |
| October, 2025 | $9.8839 | $8.6402 | $11.88 | +1,931% |
| November, 2025 | $14.27 | $9.4496 | $14.43 | +2,832% |
| December, 2025 | $7.4297 | $6.0991 | $15.32 | +1,427% |
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Price Forecast for 2026
The predicted value for Brainstorm Cell Therapeutics, Inc. (BCLI) in 2026 is set at an average of $5.435. Estimates vary from a peak of $10.23 to a trough of $0.639, indicating an +1,017% surge from the present price of $0.4866.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6923 | $1.2317 | $10.23 | +453.29% |
| February, 2026 | $2.7849 | $1.9742 | $3.3542 | +472.31% |
| March, 2026 | $2.6274 | $1.8761 | $2.9155 | +439.96% |
| April, 2026 | $4.4806 | $2.6281 | $5.6994 | +820.81% |
| May, 2026 | $1.7932 | $0.7019 | $2.6313 | +268.52% |
| June, 2026 | $1.3158 | $1.1045 | $2.3839 | +170.40% |
| July, 2026 | $1.099 | $0.639 | $1.5577 | +125.85% |
| August, 2026 | $1.7116 | $0.9796 | $1.9015 | +251.74% |
| September, 2026 | $1.2948 | $1.1248 | $1.9035 | +166.09% |
| October, 2026 | $1.8173 | $1.0361 | $2.067 | +273.48% |
| November, 2026 | $1.3699 | $1.1186 | $1.848 | +181.53% |
| December, 2026 | $1.2231 | $1.0418 | $1.7318 | +151.36% |
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Brainstorm Cell Therapeutics, Inc. (BCLI) is $1.6858, with a high forecast of $2.5728 and a low forecast of $0.7989. This indicates an +246.45% increase from the last price of $0.4866.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0557 | $1.0084 | $1.2744 | +116.95% |
| February, 2027 | $0.9483 | $0.8163 | $1.3383 | +94.87% |
| March, 2027 | $1.5215 | $0.7989 | $2.2715 | +212.67% |
| April, 2027 | $1.684 | $1.4121 | $2.5728 | +246.08% |
| May, 2027 | $1.2866 | $0.9053 | $1.6747 | +164.41% |
| June, 2027 | $1.1898 | $1.0585 | $1.4972 | +144.52% |
| July, 2027 | $1.6324 | $1.1205 | $1.7524 | +235.47% |
| August, 2027 | $1.405 | $1.355 | $1.9337 | +188.73% |
| September, 2027 | $1.3482 | $0.9969 | $1.6662 | +177.06% |
| October, 2027 | $1.3007 | $1.1107 | $1.4501 | +167.31% |
| November, 2027 | $1.2633 | $1.082 | $1.4014 | +159.62% |
| December, 2027 | $2.0065 | $1.0052 | $2.0465 | +312.35% |
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Price Forecast for 2028
In 2028, Brainstorm Cell Therapeutics, Inc. (BCLI) is projected to reach an average price of $1.6483, with a high projection of $3.2172 and a low estimate of $0.0794. This indicates an +238.73% rise from the last price of $0.4866.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.8991 | $1.6672 | $3.2172 | +290.28% |
| February, 2028 | $3.0116 | $1.6597 | $3.1516 | +518.92% |
| March, 2028 | $2.2049 | $1.6536 | $3.0823 | +353.12% |
| April, 2028 | $0.3874 | $0.1274 | $2.3023 | -20.38% |
| May, 2028 | $0.4406 | $0.0794 | $0.8306 | -9.45% |
| June, 2028 | $0.3032 | $0.1305 | $0.5325 | -37.69% |
| July, 2028 | $1.7458 | $0.1941 | $1.7758 | +258.77% |
| August, 2028 | $0.499 | $0.299 | $1.8364 | +2.55% |
| September, 2028 | $1.7316 | $0.3496 | $2.3709 | +255.85% |
| October, 2028 | $1.9541 | $1.4448 | $2.3265 | +301.59% |
| November, 2028 | $2.0573 | $1.5067 | $2.186 | +322.80% |
| December, 2028 | $1.1199 | $1.0393 | $2.368 | +130.15% |
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Price Forecast for 2029
The 2029 price forecast for Brainstorm Cell Therapeutics, Inc. Stock (BCLI) is $1.4811 on average, with a high prediction of $2.951 and a low estimate of $0.0111. This represents an +204.37% increase from the previous price of $0.4866.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.9531 | $0.5825 | $1.2035 | +95.87% |
| February, 2029 | $0.8157 | $0.545 | $1.0238 | +67.63% |
| March, 2029 | $0.1625 | $0.1489 | $0.9763 | -66.62% |
| April, 2029 | $0.5892 | $0.0111 | $0.5822 | +21.08% |
| May, 2029 | $0.5356 | $0.5556 | $0.5673 | +10.06% |
| June, 2029 | $0.4034 | $0.424 | $0.4853 | -17.10% |
| July, 2029 | $0.3478 | $0.4183 | $0.4021 | -28.52% |
| August, 2029 | $0.2143 | $0.2575 | $0.3102 | -55.96% |
| September, 2029 | $0.1761 | $0.2229 | $0.147 | -63.82% |
| October, 2029 | $0.0982 | $0.1467 | $0.1379 | -79.83% |
| November, 2029 | $0.1027 | $0.0207 | $0.3315 | -78.89% |
| December, 2029 | $3.081 | $0.0168 | $2.951 | +533.17% |
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) Price Forecast for 2030
Brainstorm Cell Therapeutics, Inc. Stock (BCLI) is expected to reach an average price of $2.0281 in 2030, with a high forecast of $3.9481 and a low forecast of $0.1081. This signifies an +316.79% surge from the last price of $0.4866.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2846 | $3.2397 | $3.2546 | +575.01% |
| February, 2030 | $2.3794 | $2.7094 | $3.0133 | +388.99% |
| March, 2030 | $3.0543 | $2.8382 | $2.7543 | +527.68% |
| April, 2030 | $2.9392 | $3.0392 | $2.9405 | +504.02% |
| May, 2030 | $2.7127 | $2.6866 | $2.5876 | +457.49% |
| June, 2030 | $2.8026 | $2.6689 | $2.6015 | +475.96% |
| July, 2030 | $2.4532 | $2.7212 | $2.685 | +404.15% |
| August, 2030 | $2.586 | $2.4099 | $2.406 | +431.45% |
| September, 2030 | $1.8509 | $1.9509 | $2.1405 | +280.38% |
| October, 2030 | $0.9135 | $1.8645 | $1.9308 | +87.73% |
| November, 2030 | $0.3894 | $0.1081 | $3.9481 | -19.99% |
| December, 2030 | $1.3242 | $1.5368 | $1.1042 | +172.14% |
0.79%
3.50%
Cap:
|
Volume (24h):